Five Plaintiffs Join Illinois Yaz MDL
On August 8, 2012, Jordynn Ligocki, Araclia Lopez, Joyce Simmons, Barbara Davenport, and Kimberly Collins filed joint lawsuits to join the Yaz MDL No. 2100 in the U.S. District Court for the Southern District of Illinois. According to their Yaz lawyer, the plaintiffs have all suffered injuries from the oral contraceptive, including pulmonary embolism and stroke, two conditions often attributed to blood clots.
Plaintiffs suffer Yaz blood clots and other conditions
According to their joint complaint, the plaintiffs were prescribed and ingested Yasmin and/or Yaz (ethinyl estadiol and drospirenone), two oral birth control medications manufactured by Bayer Pharmaceuticals. Their Yaz lawyer claims that as a result of these medications, the plaintiffs sustained serious and life-threatening injuries.
Allegedly, as a direct result of their use of Yaz or Yasmin, Jordynn Ligocki was diagnosed with pulmonary embolism on January 17, 2012; Aracelia Lopez was diagnosed with pulmonary embolism on December 26, 2006; Joyce Simmons was diagnosed with pulmonary embolism on October 24, 2011 and suffered gallbladder removal surgery on October 24, 2011; Barbara Davenport was diagnosed with Yaz blood clots on November 22, 2011; and Kimberly Collins suffered gallbladder removal surgery on March 01, 2006.
Yaz lawyer labels medications as “unreasonably dangerous”
According to the complaint, there is sufficient evidence that drospirenone, the fourth-generation progestin used in both Yasmin and Yaz, may lead to increased risk of blood clots and related conditions. In fact, the plaintiffs’ lawsuits state that Bayer “knew or should have known that the use of Yasmin and Yaz created a higher risk of blood clots than other oral contraceptives on the market, including but not limited to second generation oral contraceptives, and that, when taken as directed, such use was unreasonably dangerous to consumers.”
Nevertheless, their Yaz lawyer alleges that Bayer failed to adequately warn the plaintiffs or their health care providers of the serious risks of Yaz and Yasmin.
Yaz lawsuit claims negligence, breach of warranties
The Yaz lawsuit plaintiffs claim to have suffered “significant harm, conscious pain and suffering, physical injury and bodily impairment, including but not limited to suffering from pulmonary embolism, blood clots and/or gallbladder removal surgeries, and related sequelea requiring hospitalization, recovery therapy, continuing treatment and medical monitoring, which may have caused permanent effects, and which may continue in the future to cause physical effects and damage.”
As a result of these injuries, the women have experienced pain and suffering, bodily impairment, mental anguish and diminished enjoyment of life.
Their lawsuits claim defective manufacturing, defective design or formulation, inadequate warning nonconformance with representation, failure to adequately test, negligence, breach of express and implied warranties, and negligent misrepresentation. They request compensatory, punitive and exemplary damages, as well as medical and legal expenses.